Literature DB >> 10930133

Forskolin modulates acetylcholine receptor gating by interacting with the small extracellular loop between the M2 and M3 transmembrane domains.

Z Chen1, M M White.   

Abstract

1. Forskolin acts as an allosteric modulator of muscle-type nicotinic acetylcholine receptors. Receptors from mouse muscle and Torpedo electroplax demonstrate differential sensitivity to inhibition by forskolin. Previous work from this laboratory suggested that the gamma subunit is responsible for this differential sensitivity. 2. We have used a series of mouse/Torpedo species-chimeric gamma subunits to further define the site of forskolin interaction with the gamma subunit. Analysis of the patterns of forskolin inhibition of receptors containing mouse/Torpedo chimeric gamma subunits along with the mouse alpha, beta, and delta subunits suggests that forskolin interacts with the small extracellular domain that links the M2 and M3 transmembrane domains (the M2-M3 linker). 3. We suggest that the M2-M3 linker domain plays an important role in the transduction of ligand binding to the conformational changes that result in channel opening.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930133     DOI: 10.1023/a:1007011911611

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  35 in total

1.  Forskolin acts as a noncompetitive inhibitor of nicotinic acetylcholine receptors.

Authors:  M L Aylwin; M M White
Journal:  Mol Pharmacol       Date:  1992-05       Impact factor: 4.436

2.  Evidence that the M2 membrane-spanning region lines the ion channel pore of the nicotinic receptor.

Authors:  R J Leonard; C G Labarca; P Charnet; N Davidson; H A Lester
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

3.  Voltage jump analysis of procaine action at frog end-plate.

Authors:  P R Adams
Journal:  J Physiol       Date:  1977-06       Impact factor: 5.182

4.  The role of conserved leucines in the M2 domain of the acetylcholine receptor in channel gating.

Authors:  G N Filatov; M M White
Journal:  Mol Pharmacol       Date:  1995-09       Impact factor: 4.436

5.  Local anesthetics and histrionicotoxin are allosteric inhibitors of the acetylcholine receptor. Studies of clonal muscle cells.

Authors:  S M Sine; P Taylor
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

6.  The noncompetitive blocker [3H]chlorpromazine labels three amino acids of the acetylcholine receptor gamma subunit: implications for the alpha-helical organization of regions MII and for the structure of the ion channel.

Authors:  F Revah; J L Galzi; J Giraudat; P Y Haumont; F Lederer; J P Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  Short chain and long chain alkanols have different sites of action on nicotinic acetylcholine receptor channels from Torpedo.

Authors:  S C Wood; S A Forman; K W Miller
Journal:  Mol Pharmacol       Date:  1991-03       Impact factor: 4.436

8.  Identification of the alpha subunit half-cystine specifically labeled by an affinity reagent for the acetylcholine receptor binding site.

Authors:  P N Kao; A J Dwork; R R Kaldany; M L Silver; J Wideman; S Stein; A Karlin
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

9.  Forskolin alters acetylcholine receptor gating by a mechanism independent of adenylate cyclase activation.

Authors:  M M White
Journal:  Mol Pharmacol       Date:  1988-10       Impact factor: 4.436

10.  Modulation of acetylcholine receptor desensitization by forskolin is independent of cAMP.

Authors:  P K Wagoner; B S Pallotta
Journal:  Science       Date:  1988-06-17       Impact factor: 47.728

View more
  1 in total

1.  Isoflurane alters the structure and dynamics of GLIC.

Authors:  Dan Willenbring; Lu Tian Liu; David Mowrey; Yan Xu; Pei Tang
Journal:  Biophys J       Date:  2011-10-19       Impact factor: 4.033

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.